LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Transcript
Lifevantage NASDAQ: LFVN reported lower fourth-quarter and fiscal 2026 results as the health and wellness company faced fewer orders, lower average order sizes and a difficult comparison against prior-year sales of its MindBody GLP-1 System.
Investors need to pay close attention to LFVN stock based on the movements in the options market lately.
| Food Products Industry | Consumer Staples Sector | Terrence Moorehead CEO | XSTU Exchange | 53222K205 CUSIP |
| US Country | 232 Employees | 1 Sep 2026 Last Dividend | 19 Oct 2015 Last Split | 5 Oct 2004 IPO Date |
LifeVantage Corporation, founded in 2003 and based in Lehi, Utah, operates within the health and wellness industry focusing on the identification, research, development, formulation, and sale of advanced nutrigenomic activators and a wide array of other health-related products. These include dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company markets its products globally through a network of independent distributors, reaching multiple countries including the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. Its product offerings are sold primarily through its website, leveraging the direct selling model to foster personal connections between its distributors and customers.